NKE
39
2
PBI
58
8
BXP
52
-2
AFL
66
2
URI
63
3
CSX
39
-4
AVY
77
2
URBN
60
-3
LYB
41
4
KSS
47
-4
EXC
58
11
AAL
50
2
WY
36
5
BWA
61
-7
MTCH
44
-2
PFE
37
-3
EL
55
-3
COP
47
2
JCI
44
2
CFG
56
4
NKE
39
2
PBI
58
8
BXP
52
-2
AFL
66
2
URI
63
3
CSX
39
-4
AVY
77
2
URBN
60
-3
LYB
41
4
KSS
47
-4
EXC
58
11
AAL
50
2
WY
36
5
BWA
61
-7
MTCH
44
-2
PFE
37
-3
EL
55
-3
COP
47
2
JCI
44
2
CFG
56
4
Financhill
Back

Cumberland Pharmaceuticals Quote, Financials, Valuation and Earnings

Sell
35

CPIX
Cumberland Pharmaceuticals

Last Price:
1.58
Seasonality Move:
-0.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Cumberland Pharmaceuticals Price Quote

$1.58
+0.07 (+5.33%)
(Updated: May 18, 2024 at 5:40 AM ET)

Cumberland Pharmaceuticals Key Stats

Sell
35
Cumberland Pharmaceuticals (CPIX) is a Sell
Day range:
$1.50 - $1.58
52-week range:
$1.42 - $2.36
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.56
P/B ratio:
0.78%
Volume:
4.1K
Avg. volume:
9K
1-year change:
-13.22%
Market cap:
$21.4M
Revenue:
$39.6M
EPS:
$-0.59

How Much Does Cumberland Pharmaceuticals Make?

Is Cumberland Pharmaceuticals Growing As A Company?

Cumberland Pharmaceuticals Stock Price Performance

What Is Cumberland Pharmaceuticals 52-Week High & Low?

Cumberland Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Cumberland Pharmaceuticals?

Is Cumberland Pharmaceuticals Cash Flow Positive?

  • What Is CPIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $5.4M
  • What Is Cumberland Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$3.2M
  • What Is Cumberland Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $10.6K

Cumberland Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CPIX return on invested capital is -17.83%
  • What Is Cumberland Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -9.79%
  • What Is CPIX Return On Equity?
    ROE is a measure of profitability and is -25.51%

Cumberland Pharmaceuticals Earnings Date & Stock Price

Cumberland Pharmaceuticals Competitors

Cumberland Pharmaceuticals Dividend Yield

Data Unavailable

Cumberland Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 98.43%
Revenue: -7.88% 5.65%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.50
Upside from Last Price: 462.91%

Major Shareholders

  • How many CPIX shares are owned by institutional investors?
    3.1M CPIX shares are owned by institutional investors
  • How many CPIX shares are owned by insiders?
    7.6M CPIX shares are owned by insiders